We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
(-11%)
Cap. Flow
+$47.8M
Cap. Flow
% of AUM
7.17%
Top 10 Holdings %
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Relay Therapeutics
RLAY
|
+$3.83M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$3M |
| 3 |
Teck Resources
TECK
|
+$2.87M |
| 4 |
MODV
ModivCare
MODV
|
+$2.67M |
| 5 |
Genpact
G
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.07M |
| 2 |
CHS
Chicos FAS, Inc.
CHS
|
+$2.68M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$2.45M |
| 4 |
Crane NXT
CXT
|
+$2.44M |
| 5 |
ATCO
Atlas Corp.
ATCO
|
+$2.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.12% |
| 2 | Technology | 15.11% |
| 3 | Consumer Discretionary | 12.76% |
| 4 | Industrials | 12.53% |
| 5 | Financials | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
El Pollo Loco
LOCO
$462M
| $130K | 0.02% |
13,196
+2,531
| +24% | +$26.6K |
|
|
FOLD
1177
DELISTED
Amicus Therapeutics
FOLD
| $129K | 0.02% |
+12,023
| New | +$99K |
|
|
SEI
1178
Solaris Energy Infrastructure
SEI
$3.55B
| $129K | 0.02% |
11,835
-3,842
| -25% | -$46.2K |
|
1179
Commercial Vehicle Group
CVGI
$147M
| $128K | 0.02% |
+21,873
| New | +$149K |
|
1180
Rapid Micro Biosystems
RPID
$86.2M
| $128K | 0.02% |
+29,835
| New | +$139K |
|
|
RWT
1181
Redwood Trust
RWT
$594M
| $127K | 0.02% |
16,478
-79,121
| -83% | -$727K |
|
|
JOAN
1182
DELISTED
JOANN, Inc. Common Stock
JOAN
| $127K | 0.02% |
16,377
-4,113
| -20% | -$37.7K |
|
|
ATHX
1183
DELISTED
Athersys, Inc. Common Stock
ATHX
| $127K | 0.02% |
19,479
-4,133
| -18% | -$45.7K |
|
|
AGNT
1184
AGNT Inc
AGNT
$734M
| $124K | 0.02% |
+10,556
| New | +$153K |
|
1185
Vera Bradley
VRA
$98.7M
| $124K | 0.02% |
+28,606
| New | +$175K |
|
|
NMTR
1186
DELISTED
9 Meters Biopharma
NMTR
| $122K | 0.02% |
23,460
+2,467
| +12% | +$23.2K |
|
|
SPNE
1187
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $122K | 0.02% |
21,622
-30,544
| -59% | -$266K |
|
|
GBIO
1188
DELISTED
Generation Bio
GBIO
| $121K | 0.02% |
+1,846
| New | +$121K |
|
1189
Ironwood Pharmaceuticals
IRWD
$711M
| $121K | 0.02% |
10,501
-71,480
| -87% | -$842K |
|
1190
VistaGen Therapeutics
VTGN
$12.8M
| $121K | 0.02% |
4,598
+2,132
| +86% | +$75.3K |
|
1191
Full House Resorts
FLL
$88.1M
| $120K | 0.02% |
+19,755
| New | +$152K |
|
1192
Macerich
MAC
$6.92B
| $119K | 0.02% |
+13,712
| New | +$166K |
|
1193
Grab
GRAB
$14.9B
| $118K | 0.02% |
+46,728
| New | +$134K |
|
|
NETI
1194
DELISTED
Eneti Inc.
NETI
| $118K | 0.02% |
19,168
+7,193
| +60% | +$46.1K |
|
1195
Gaotu Techedu
GOTU
$436M
| $117K | 0.02% |
+59,871
| New | +$96K |
|
|
NKLA
1196
DELISTED
Nikola Corporation Common Stock
NKLA
| $115K | 0.02% |
803
-366
| -31% | -$74.8K |
|
1197
Goodyear
GT
$1.85B
| $114K | 0.02% |
+10,651
| New | +$133K |
|
|
VIEW
1198
DELISTED
View, Inc. Class A Common Stock
VIEW
| $114K | 0.02% |
+1,175
| New | +$104K |
|
|
HBI
1199
DELISTED
Hanesbrands
HBI
| $113K | 0.02% |
10,999
-11,408
| -51% | -$142K |
|
1200
Liquidia Corp
LQDA
$8.02B
| $113K | 0.02% |
+25,806
| New | +$133K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.
GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.
- GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
- GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
- GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
- GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
- GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
- GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
- GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.
Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.